Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. L.M. Prens

Publicaties

Assessment tools and phenotype classification for hidradenitis suppurativa

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study

New Insights in Hidradenitis Suppurativa from a Population-based Dutch Cohort: Prevalence, Smoking Behaviour, Socioeconomic Status and Comorbidities

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study

Hidradenitis suppurativa beyond the skin: from pathogenesis to disease burden

Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey study

Impact of hidradenitis suppurativa on work productivity and associated risk factors

No evident systemic terminal complement pathway activation in hidradenitis suppurativa

No Evident Systemic Terminal Complement Pathway Activation in Hidradenitis Suppurativa

Lees meer